163 related articles for article (PubMed ID: 35886951)
1. Vasopressin Receptor Type-2 Mediated Signaling in Renal Cell Carcinoma Stimulates Stromal Fibroblast Activation.
Jamadar A; Dwivedi N; Mathew S; Calvet JP; Thomas SM; Rao R
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886951
[TBL] [Abstract][Full Text] [Related]
2. Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy.
Sinha S; Dwivedi N; Tao S; Jamadar A; Kakade VR; Neil MO; Weiss RH; Enders J; Calvet JP; Thomas SM; Rao R
Oncogene; 2020 Feb; 39(6):1231-1245. PubMed ID: 31616061
[TBL] [Abstract][Full Text] [Related]
3. Epithelial Vasopressin Type-2 Receptors Regulate Myofibroblasts by a YAP-CCN2-Dependent Mechanism in Polycystic Kidney Disease.
Dwivedi N; Tao S; Jamadar A; Sinha S; Howard C; Wallace DP; Fields TA; Leask A; Calvet JP; Rao R
J Am Soc Nephrol; 2020 Aug; 31(8):1697-1710. PubMed ID: 32554753
[TBL] [Abstract][Full Text] [Related]
4. V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists.
Takahashi K; Makita N; Manaka K; Hisano M; Akioka Y; Miura K; Takubo N; Iida A; Ueda N; Hashimoto M; Fujita T; Igarashi T; Sekine T; Iiri T
J Biol Chem; 2012 Jan; 287(3):2099-106. PubMed ID: 22144672
[TBL] [Abstract][Full Text] [Related]
5. Delivery of miR-224-5p by Exosomes from Cancer-Associated Fibroblasts Potentiates Progression of Clear Cell Renal Cell Carcinoma.
Liu Y; Fu W; Cao X; Li S; Xiong T; Zhang X; Wu X; Cheng L; Wei Y; Gao B
Comput Math Methods Med; 2021; 2021():5517747. PubMed ID: 34122615
[TBL] [Abstract][Full Text] [Related]
6. Clear cell renal cell carcinoma induces fibroblast-mediated production of stromal periostin.
Bakhtyar N; Wong N; Kapoor A; Cutz JC; Hill B; Ghert M; Tang D
Eur J Cancer; 2013 Nov; 49(16):3537-46. PubMed ID: 23896380
[TBL] [Abstract][Full Text] [Related]
7. The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors.
Juul KV; Bichet DG; Nielsen S; Nørgaard JP
Am J Physiol Renal Physiol; 2014 May; 306(9):F931-40. PubMed ID: 24598801
[TBL] [Abstract][Full Text] [Related]
8. YAP is overexpressed in clear cell renal cell carcinoma and its knockdown reduces cell proliferation and induces cell cycle arrest and apoptosis.
Cao JJ; Zhao XM; Wang DL; Chen KH; Sheng X; Li WB; Li MC; Liu WJ; He J
Oncol Rep; 2014 Oct; 32(4):1594-600. PubMed ID: 25175178
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts in renal cell carcinoma: implication in prognosis and resistance to anti-angiogenic therapy.
Ambrosetti D; Coutts M; Paoli C; Durand M; Borchiellini D; Montemagno C; Rastoin O; Borderie A; Grepin R; Rioux-Leclercq N; Bernhard JC; Pagès G; Dufies M
BJU Int; 2022 Jan; 129(1):80-92. PubMed ID: 34107167
[TBL] [Abstract][Full Text] [Related]
10. Adaptation to sustained high plasma vasopressin in water and electrolyte homeostasis in the rat transgenic for the metallothionein-vasopressin fusion gene.
Yokoi H; Nagasaki H; Tachikawa K; Arima H; Murase T; Miura Y; Hirabayashi M; Oiso Y
J Endocrinol; 2002 Apr; 173(1):23-33. PubMed ID: 11927381
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin specific peptidase 19 is a prognostic biomarker and affect the proliferation and migration of clear cell renal cell carcinoma.
Hu W; Su Y; Fei X; Wang X; Zhang G; Su C; Du T; Yang T; Wang G; Tang Z; Zhang J
Oncol Rep; 2020 Jun; 43(6):1964-1974. PubMed ID: 32236633
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA PCAT1 drives clear cell renal cell carcinoma by upregulating YAP via sponging miR-656 and miR-539.
Wang R; Zheng B; Liu H; Wan X
Cell Cycle; 2020 May; 19(10):1122-1131. PubMed ID: 32286142
[TBL] [Abstract][Full Text] [Related]
13. FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway.
Lv Q; Wang G; Zhang Y; Han X; Li H; Le W; Zhang M; Ma C; Wang P; Ding Q
Int J Oncol; 2019 Apr; 54(4):1221-1232. PubMed ID: 30968158
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the vasopressin V2 receptor by vasopressin in polarized renal collecting duct cells.
Robben JH; Knoers NV; Deen PM
Mol Biol Cell; 2004 Dec; 15(12):5693-9. PubMed ID: 15469988
[TBL] [Abstract][Full Text] [Related]
15. Vasopressin V2 receptor, tolvaptan, and ERK1/2 phosphorylation in the renal collecting duct.
Khan S; Raghuram V; Chen L; Chou CL; Yang CR; Khundmiri SJ; Knepper MA
Am J Physiol Renal Physiol; 2024 Jan; 326(1):F57-F68. PubMed ID: 37916285
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
[TBL] [Abstract][Full Text] [Related]
17. PTPN13 acts as a tumor suppressor in clear cell renal cell carcinoma by inactivating Akt signaling.
Long Q; Sun J; Lv J; Liang Y; Li H; Li X
Exp Cell Res; 2020 Nov; 396(1):112286. PubMed ID: 32919955
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of microRNA-1274a induces cell apoptosis through regulation of BMPR1B in clear cell renal cell carcinoma.
Yoshino H; Yonezawa T; Yonemori M; Miyamoto K; Sakaguchi T; Sugita S; Osako Y; Tatarano S; Nakagawa M; Enokida H
Oncol Rep; 2018 Jan; 39(1):173-181. PubMed ID: 29192325
[TBL] [Abstract][Full Text] [Related]
19. VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonist.
Rihakova L; Quiniou C; Hamdan FF; Kaul R; Brault S; Hou X; Lahaie I; Sapieha P; Hamel D; Shao Z; Gobeil F; Hardy P; Joyal JS; Nedev H; Duhamel F; Beauregard K; Heveker N; Saragovi HU; Guillon G; Bouvier M; Lubell WD; Chemtob S
Am J Physiol Regul Integr Comp Physiol; 2009 Oct; 297(4):R1009-18. PubMed ID: 19641130
[TBL] [Abstract][Full Text] [Related]
20. Targeting a positive regulatory loop in the tumor-macrophage interaction impairs the progression of clear cell renal cell carcinoma.
Wang C; Wang Y; Hong T; Ye J; Chu C; Zuo L; Zhang J; Cui X
Cell Death Differ; 2021 Mar; 28(3):932-951. PubMed ID: 33009518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
